Proton pump inhibitor use status does not modify the microbiome signature for cirrhosis
- PMID: 33657386
- DOI: 10.1016/j.cmet.2021.02.013
Proton pump inhibitor use status does not modify the microbiome signature for cirrhosis
Abstract
Oh et al. address concerns about the influence of proton pump inhibitor (PPI) use on a gut microbiome signature for cirrhosis. By removing PPI using subjects from the training cohort and retraining a 19-species Random Forest model, they demonstrate the impact of PPI usage on the signature's diagnostic accuracy is minimal.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no conflicts of interest.
Comment on
-
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis.Cell Metab. 2020 Nov 3;32(5):878-888.e6. doi: 10.1016/j.cmet.2020.06.005. Epub 2020 Jun 30. Cell Metab. 2020. PMID: 32610095 Free PMC article.
-
Treatment regimens may compromise gut-microbiome-derived signatures for liver cirrhosis.Cell Metab. 2021 Mar 2;33(3):455-456. doi: 10.1016/j.cmet.2021.02.012. Cell Metab. 2021. PMID: 33657385
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
